![Elizabeth A. Whayland](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elizabeth A. Whayland
Plus aucun poste en cours
Profil
Elizabeth A.
Whayland has been Senior Vice President of Finance for CuraGen Corp.
since October 2005 and Corporate Secretary since 1997.
Previously, she was Vice President of Finance for CuraGen from 2003 to September 2005 and Director of Financial Management from 1994 to 2002.
She was Senior Manager of Deloitte & Touche LLP.
Ms. Whayland received a BA from Grove City College and an MST from the University of Hartford.
Anciens postes connus de Elizabeth A. Whayland
Sociétés | Poste | Fin |
---|---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Directeur Financier/CFO | 01/01/2008 |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Elizabeth A. Whayland
Grove City College | Undergraduate Degree |
University of Hartford | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |